⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 23, 2025VaccinesOpen Access

Special Issue: Vaccines and Vaccinations in the Pandemic

Dimitrios Papagiannis Georgios Rachiotis

View Full Paper

Ask AI

Bookmark

Share

Key Points

The rapid development of COVID-19 vaccines sets a historic precedent in medical science and public health.
Utilizing mRNA technology, multiple vaccines were developed in an unprecedented timeframe to combat the pandemic.
This overview examines the impact of vaccines on public health, emphasizing the importance of rapid innovation.
The findings support continued investment in vaccine technology to prepare for future pandemics and health crises.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

This special issue reveals insights on vaccine development during the COVID-19 pandemic, highlighting mRNA technology's role.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Papagiannis et al. (2025) studied this question.

synapsesocial.com/papers/68d4757f31b076d99fa6ce6b https://doi.org/10.3390/vaccines13100992

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Special Issue: Novel Vaccines and Vaccine Technologies for Emerging InfectionsOriginal Research · 2026
2Vaccine Development in the Era of Emerging Infectious Diseases2025
3Immune Response to COVID-19 Vaccines: Updates in a Fast-Moving ScenarioReview · 2026
4THE FEATURES OF ADVANCES AND CHALLENGES IN COVID-19 VACCINE DEVELOPMENT, EFFICACY, SAFETY, AND GLOBAL DEPLOYMENT IN GENERAL2025
5From discovery through emergency use to the present: Safety evaluation of the COVID-19 mRNA-1273 (Moderna) vaccineReview · 2026 · 1 citations

More related papers

The future of vaccination: Innovations emerging from the COVID-19 pandemic2026
Emerging vaccines for emerging diseases: Innovations in immunization strategies to address global health challenges2024
Toxicologic Pathology Forum*: mRNA Vaccine Safety–Separating Fact From Fiction2024

More from Vaccines

Plant-Based Virus-like Particle (VLP) Vaccines Against Influenza and Hepatitis VirusesTue,
Adverse Events Following Varicella-Containing Vaccination in Healthy Children: A Systematic Review and Meta-AnalysisTue,